Though we observed dampened expression of NF-kB target genes in p53-deficient melanoma cells, TNF-α treatment activates NF-kB and increases the expression of its target genes in melanoma cell lines regardless of p53 status. The gene discussed is NFKB1; the disease is melanoma.